This on-demand presentation explores how top-down mass spectrometry (MS/MS) provides direct and quantitative assessments of highly modified CRISPR guide RNAs (gRNAs), ensuring their accuracy and safety for therapeutic applications.
Discover:
This presentation is for you if:
Don't miss this opportunity to learn how top-down MS/MS can revolutionize your CRISPR research and development.
By the end of this presentation, you will have:
Luis A. Macias, Ph.D., Mass Spectrometry Scientist, Verve Therapeutics, Houston, TX, USA
For Research Use Only. Not for use in clinical diagnostic procedures.